NREP
NEW REPRESENTATIVE AT IB RECEIVED
12/18/2025
Back to search
Official data from USPTO
XPERT ALLIANCE RENTSCHLER & VETTER SUBSTANCE PRODUCT PATIENT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Quick snapshot
ST13
US500000079362259Class
39, 40, 42, 44
Filing
79362259
Registration
7334071
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
12/19/2025
Trademark type
Combined
Nice classes
39, 40, 42, 44
Filing date
05/23/2022
Registration date
03/26/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/26/2024
Last transaction
12/19/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
DE
Examiner
OAKES,JEFFREY ALLEN
Law office
O10
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stacked wording "XPERT ALLIANCE" in blue. To the right of the term "XPERT" appears the wording "RENTSCHLER" in orange above the wording "& VETTER" in orange. All the aforesaid appears above the wording "SUBSTANCE PRODUCT PATIENT" in black with these terms separated by orange triangles.
Holders and representatives
Holders
R. S. (pessoa física)
Vetter Pharma-Fertigung GmbH & Co. KG
Representatives
Walter Hill Levie III MEUNIER CARLIN & CURFMAN LLC
Technical classification
Nice Classes
Class 39Class 40Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 39
Bottling services and storage of goods in the nature of liquid and solid substancesespeciallypharmaceuticalsmedicines and solutionsfor others
Class 40
Contract manufacturing in the field of pharmaceuticals and pharmaceutical substances; custom manufacture of veterinary preparations and substances; custom manufacture of diagnostic preparations and substances for medical and veterinary use; custom manufacture of biopharmaceuticals; processing of biopharmaceutical materials for others; consultancy services relating to custom manufacturing process services; assembly of products for otherscustom manufacture and assembly servicescustom assembly for others of electronic components for medical devices and apparatussemiconductor components and circuit switches; consultancy and information for the customised manufacture and production processes for electronic componentssemi-conductor components and circuits for medical apparatus and equipment
Class 42
Scientific and technological servicesscientific researchanalysistesting and development in the field of biomanufacturing and in the pharmaceutical field and research and design relating thereto; industrial analysis and research serviceschemicalbiochemicalbiological and bacteriological research and analysis and industrial research in the field of pharmaceuticals; chemistry serviceschemistry consultationresearch in the fields of chemistry; biochemical servicesbiochemistry consultationresearch in the fields of biochemistry; services of medicalbacteriological and chemical laboratorieslaboratory research and laboratory analysis; research on the subject of pharmaceuticals; biochemistry research services; development of pharmaceuticalveterinary and diagnostic products and substances and methods for the manufacture thereofin particular using biotechnological and genetically-engineered meansin the nature of research in the field of manufacturing machinery for pharmaceuticalveterinary and diagnostic products and substancesdesign and development of computer hardware for the pharmaceuticalveterinary and diagnostic products and substances manufacturing industries; technological consultancy relating to pharmacyconsulting services in the field of pharmaceutical research and developmenttechnical consulting in the field of pharmaceutical studies; technological consultancy in the veterinary research field; technological consultancy in the field of diagnosticsconsulting services in the field of pharmaceutical research and developmentconsulting services in the field of pharmacogenetics; quality control for others; providing information and data relating to medical research and development; development of syringes and instruments for injectionsinjectors and packaging for the aforesaid goods for others; product quality and product safety testingchemical testingphysical testing and process engineering testingin particular laboratory testing; pharmacological and microbiological developmentresearch and analysis for others; conducting clinical testsscientific research in the nature of conducting clinical trials for others; conducting technical project studies in the nature of scientific feasibility studies and technological support services being technological research in the field of pharmaceutical agent manufacturing processes and pharmaceutical co-filling and packaging processes; industrial manufacturing process development consultancy
Class 44
Medical services; medical assistance; animal healthcare servicesanimal breedinganimal groomingmedical analysis services for diagnostic and treatment purposes; consultancy and information services relating to biopharmaceutical productsproviding medical information and pharmaceutical consultation in the nature of a medical consultation relating to biopharmaceutical products
Publications
History of USPTO decisions and trademark events.
30 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
11/23/2024
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
10/08/2024
XXCR
GENERIC MADRID TRANSACTION CREATED
10/08/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/27/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/26/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
03/26/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/09/2024
PUBO
PUBLISHED FOR OPPOSITION
01/09/2024
GPNX
NOTIFICATION PROCESSED BY IB
01/08/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/20/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
12/20/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/20/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/05/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
12/05/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/05/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
12/05/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/05/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/09/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/09/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/09/2023
RFNP
REFUSAL PROCESSED BY IB
06/07/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
05/12/2023
RFRR
REFUSAL PROCESSED BY MPU
05/11/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/22/2023
CNRT
NON-FINAL ACTION WRITTEN
03/21/2023
DOCK
ASSIGNED TO EXAMINER
03/11/2023
MAFR
APPLICATION FILING RECEIPT MAILED
02/14/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/10/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/09/2023
Continuous trademark protection
Get notified about every new filing that threatens XPERT ALLIANCE RENTSCHLER & VETTER SUBSTANCE PRODUCT PATIENT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.